Hyperfractionated or accelerated hyperfractionated re-irradiation with ≥42 Gy in combination with paclitaxel for secondary/recurrent head-and-neck cancer

Dirk Rades*, Tobias Bartscht, Christian Idel, Steven E. Schild, Samer G. Hakim

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Hyperfractionated or accelerated hyperfractionated re-irradiation with ≥42 Gy in combination with paclitaxel for secondary/recurrent head-and-neck cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences